133 related articles for article (PubMed ID: 31977119)
1. Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors.
Stensvold E; Stadskleiv K; Myklebust TÅ; Wesenberg F; Helseth E; Bechensteen AG; Brandal P
Acta Paediatr; 2020 Sep; 109(9):1875-1886. PubMed ID: 31977119
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological functioning in survivors of childhood medulloblastoma/CNS-PNET: The role of secondary medical complications.
Stadskleiv K; Stensvold E; Stokka K; Bechensteen AG; Brandal P
Clin Neuropsychol; 2022 Apr; 36(3):600-625. PubMed ID: 32729777
[No Abstract] [Full Text] [Related]
3. Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival.
Stensvold E; Myklebust TÅ; Cappelen J; Due-Tønnessen BJ; Due-Tønnessen P; Kepka A; Johannesen TB; Krossnes B; Lundar T; Maric S; Miletic H; Moholdt V; Myrmel KS; Nordberg T; Rydland J; Stokland T; Solem K; Solheim O; Torsvik I; Wikran GC; Zeller B; Wesenberg F; Bechensteen AG; Brandal P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27910. PubMed ID: 31264356
[TBL] [Abstract][Full Text] [Related]
4. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
6. Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study.
King AA; Seidel K; Di C; Leisenring WM; Perkins SM; Krull KR; Sklar CA; Green DM; Armstrong GT; Zeltzer LK; Wells E; Stovall M; Ullrich NJ; Oeffinger KC; Robison LL; Packer RJ
Neuro Oncol; 2017 May; 19(5):689-698. PubMed ID: 28039368
[TBL] [Abstract][Full Text] [Related]
7. Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor.
Koral K; Roy D; Timmons CF; Gargan L; Bowers DC
Acad Radiol; 2012 Jan; 19(1):35-9. PubMed ID: 22054800
[TBL] [Abstract][Full Text] [Related]
8. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
[TBL] [Abstract][Full Text] [Related]
9. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
[TBL] [Abstract][Full Text] [Related]
10. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.
Kao GD; Goldwein JW; Schultz DJ; Radcliffe J; Sutton L; Lange B
Cancer; 1994 Aug; 74(3):965-71. PubMed ID: 8039126
[TBL] [Abstract][Full Text] [Related]
11. Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET.
Tanem KE; Stensvold E; Wilberg P; Skaare AB; Singh PB; Brandal P; Herlofson BB
Support Care Cancer; 2022 Jul; 30(7):6155-6162. PubMed ID: 35426047
[TBL] [Abstract][Full Text] [Related]
12. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
13. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
[TBL] [Abstract][Full Text] [Related]
14. Incidence and survival of children and young people with central nervous system embryonal tumours in the North of England, 1990-2013.
Fairley L; Picton SV; McNally RJ; Bailey S; McCabe MG; Feltbower RG
Eur J Cancer; 2016 Jul; 61():36-43. PubMed ID: 27151553
[TBL] [Abstract][Full Text] [Related]
15. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
Allen JC; Donahue B; DaRosso R; Nirenberg A
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
[TBL] [Abstract][Full Text] [Related]
16. [CNS primitive neuroectodermal tumor suspected as a secondary recurrence after radiation therapy for medulloblastoma:a case report].
Sato H; Shibuya K; Koizumi T; Kato S; Endo S
No Shinkei Geka; 2014 Jul; 42(7):641-50. PubMed ID: 25006105
[TBL] [Abstract][Full Text] [Related]
17. Late recurrence of primitive neuroectodermal tumor/medulloblastoma.
Lefkowitz IB; Packer RJ; Ryan SG; Shah N; Alavi J; Rorke LB; Sutton LN; Schut L
Cancer; 1988 Aug; 62(4):826-30. PubMed ID: 2840194
[TBL] [Abstract][Full Text] [Related]
18. Cognitive deficits and psychopathological symptoms among children with medulloblastoma.
Szentes A; Erős N; Kekecs Z; Jakab Z; Török S; Schuler D; Hauser P; Garami M
Eur J Cancer Care (Engl); 2018 Nov; 27(6):e12912. PubMed ID: 30204287
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor.
Harris RD; Richard MA; Gramatges MMJ; Wilhelm K; Scheurer ME; Lupo PJ; Brown AL
Pediatr Hematol Oncol; 2023 May; 40(4):407-411. PubMed ID: 35862575
[TBL] [Abstract][Full Text] [Related]
20. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
